Human model systems at heart of new Roche project

Roche (SIX: ROG) has announced the launch of the Institute of Human Biology (IHB), focussing on advancing research in the field of human model systems such as organoids.

Using these systems, the institute aims to accelerate drug discovery and development by improving the understanding of how organs function and how diseases develop.

The Swiss pharma giant is confident that, ultimately, this will help to bring medicines to patients faster and will also enable early testing of which drug candidates are safe and which molecules would work best for each patient.